PGP-4008
Product Specifications
UNSPSC Description
PGP-4008 is a specific P-glycoprotein (Pgp) inhibitor. PGP-4008 inhibits tumor growth in a murine syngeneic Pgp-mediated multiple agent resistance (MDR) solid tumor model when given in combination with Doxorubicin[1].
Target Antigen
P-glycoprotein
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pgp-4008.html
Purity
99.69
Solubility
DMSO : 62.5 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
O=C(CC1=CC=CC=C1)NC2=C3C(N(CC3)CC4=CC=CC=C4)=NC5=CC=CC=C25
Molecular Weight
393.48
References & Citations
[1]Brian D Lee, et al. Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein. J Med Chem. 2004 Mar 11;47(6):1413-22.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-119823/PGP-4008-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-119823/PGP-4008-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
365565-02-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
DL-TNFRSF4-Hu 96 Tests
Human Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4) ELISA Kit
Ask
View Details ![Rabbit Monoclonal Endoglin/CD105 Antibody (ENG/8961R) [Janelia Fluor 669]](https://cdn.genprice.uk/genprice/genprice2.png)
NBP3-24336JF669 0.1 mL
Rabbit Monoclonal Endoglin/CD105 Antibody (ENG/8961R) [Janelia Fluor 669]
Ask
View Details 